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Abstract
Objective: Continuous invasive arterial blood pressure (IBP) monitoring remains the gold
standard for BP measurement, but traditional oscillometric non-invasive intermittent pressure
(NIBP) measurement is used in most low-to-moderate risk procedures. This study compared non-
invasive continuous arterial BP measurement using a Nexfin monitor with NIBP and IBP
monitors.
Methods: This was a single-centre, prospective, pilot study in patients scheduled for elective
orthopaedic surgery. Systolic BP, diastolic BP and mean arterial blood pressure (MAP) were
measured by Nexfin, IBP and NIBP at five intraoperative time-points. Pearson correlation
coefficients, Bland–Altman plots and trending ability of Nexfin measurements were used as
criteria for success in the investigation of measurement reliability.
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Results: A total of 20 patients were enrolled in the study. For MAP, there was a sufficient
correlation between IBP/Nexfin (Pearson¼ 0.75), which was better than the correlation
between IBP/NIBP (Pearson¼ 0.70). Bland–Altman analysis of the data showed that compared
with IBP, there was a higher percentage error for MAPNIBP (30%) compared with MAPNexfin
 (27%).
Nexfin and NIBP underestimated systolic BP; NIBP also underestimated diastolic BP and MAP.
Trending ability for MAPNexfin
 and MAPNIBP were comparable to IBP.
Conclusion: Non-invasive BP measurement with Nexfin was comparable with IBP and tended to
be more precise than NIBP.
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Introduction
Continuous invasive arterial pressure meas-
urement using an indwelling catheter is the
gold standard method for continuous blood
pressure (BP) monitoring.1 However, invasive
monitoring devices are associated with certain
risks such as infection, bleeding and ischae-
mia.2 Newer non-invasive approaches of
continuous arterial pressure monitoring rep-
resent promising alternatives. Based on the
volume-clamp method,3 the Nexﬁn monitor
(Edwards LifeSciences Corporation, Irvine,
CA, USA), a device that measures cardiac
output continuously by an inﬂatable ﬁnger
cuﬀ, provides the clinician with a continuous
reconstructed arterial pressure waveform
after physiological calibration.4–8 In cardio-
thoracic surgery, BP measured noninvasively
with a Nexﬁn ﬁnger cuﬀ that uses photo-
plethysmographic technology, was highly
comparable with BP measured invasively
both intraoperatively and postoperatively9,10
However, in critically ill patients, Nexﬁn
derived measurements did not correlate with
traditional invasive measurements.11
Reconstructive orthopaedic surgery is
expected to increase as the proportion of
the population over 64 years increases.12
Indeed, patients undergoing reconstructive
orthopaedic surgery are often elderly with a
high incidence of comorbidity (e.g. obesity,
coronary artery disease [CAD]). Several stu-
dies have shown that acute haemodynamic
impairment, including arterial hypotension,
leads to increased complication rates in both
surgical and elderly patients.13–15 The use of a
non-invasive device for continuous BP moni-
toring in moderate risk orthopaedic surgery
might be beneﬁcial if it is shown to provide
reliable measurements.16
The purpose of this pilot study was to
investigate whether non-invasive continuous
arterial pressure measurements using the
Nexﬁn monitor were comparable with
those obtained by traditional oscillometric
non-invasive intermittent BP (NIBP) moni-
toring and continuous invasive BP (IBP)
measurements in patients undergoing mod-
erate risk orthopaedic surgery.
Patients and methods
Patients
Patients were eligible for inclusion in this
prospective single-centre study if they were
18 years of age, required total hip or knee
replacement under general anaesthesia, had
a requirement for invasive arterial pressure
monitoring due to pre-existing disease or
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general condition (e.g. obesity with a body
mass index [BMI] >30 kg/m2), CAD, per-
ipheral artery disease and had limited exer-
cise capacity (i.e. were moderate risk).17
Patients were excluded from the study if
they presented with atrial ﬁbrillation, per-
ipheral vascular disease (i.e. Fontaine sta-
dium>IIa),18 scleroderma, an arteriovenous
shunt, valvular heart disease, an acute infec-
tion and/or systemic inﬂammatory response
syndrome/sepsis, required intraoperative
transfusion of >4 units of packed red blood
cells, or were pregnant and/or breastfeeding.
Following Institutional Review Board
approval by the Charite´ Ethics Committee
and patients´ written informed consent, the
study took place at Campus Charite´ Mitte
and Campus Virchow-Klinikum, Charite´ -
Universita¨tsmedizin Berlin, Charite´platz,
Berlin, Germany between April 2011 and
April 2012 (study protocol number: EA1/
199/10) (trial registration: ClinGov.
NCT01263990).
Perioperative management
For those patients who required premedica-
tion, 0.05 – 0.1mgkg1 midazolam was
given orally approximately 1 h before sur-
gery. After the insertion of a peripheral
venous line and assessment of baseline vital
signs (i.e. heart rate and pulse oximetry),
oscillometric NIBP was recorded on the
ipsilateral arm in relation to the operative
site. An arterial line was placed into the radial
artery contralateral to the NIBP using local
anaesthesia and was subsequently connected
to a pressure transducer. An appropriate
ﬁnger cuﬀ connected to the Nexﬁn device
was then placed on the medial phalanx of
the second or third ﬁnger on the same side
of the body that was used for the IBP
assessment.
General anaesthesia was conducted
according to our institutional standard
operating procedures. In brief, anaesthesia
was induced with 1.5–3mgkg1 propofol
and 1–3 mg.kg1 fentanyl followed by
0.1–0.15mg kg1 cisatracurium to facilitate
orotracheal intubation. After tracheal intub-
ation, the patients were pressure controlled
ventilated with a tidal volume of 8–
10ml kg19,20 and a respiratory rate adjusted
to maintain normocapnia (i.e. end tidal CO2
30–35mmHg, inspired oxygen fraction
0.35). Anaesthesia was maintained with
either sevoﬂurane (1 MAC Vol% end tidal)
or 6mg kg1h1 propofol, both without
nitrous oxide. Repeated doses of cisatracur-
ium were administered according to clinical
demand. For hip surgery, patients were
positioned supine with the ipsilateral arm
elevated in a 90 angle to allow optimized
access to the hip. For knee surgery, patients
were positioned in a supine position with
both arms outstretched. Sevoﬂurane or
propofol were discontinued before comple-
tion of skin closure. Patients were extubated
when they responded to verbal commands
and respiratory eﬀorts were within the
normal clinical range. Patients were trans-
ferred to the recovery room and received
oxygen via a facemask at rate of 2–4 l.min1
if needed. Patients remained in the recovery
room until they fulﬁlled the standard criteria
for discontinuation of monitoring.
Haemodynamic measurements
Following zero calibration of the IBP trans-
ducer (TruWaveTM Pressure Monitoring
Set; Edwards Lifesciences, Irvine, CA,
USA) and physiological calibration of the
Nexﬁn monitor, six BP measurements
using the Riva-Rocci technique,8 were
taken (i.e. immediately before induction
[T0] and at 3, 15, 20 and 30min after
induction of general anaesthesia as well as
immediately before the end of surgery
[TEnd]) using all three methods of monitor-
ing. At each assessment, systolic BP, dia-
stolic BP, and mean arterial pressure (MAP)
were recorded by four of the authors (F.B.,
M.H., J.S. and S.T.). Nexﬁn values were
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taken immediately before insuﬄation of the
NIBP cuﬀ to avoid triggering the need for
Physiocal, which analyses the curvature
and sharpness of the plethysmogram during
short periods of steady cuﬀ pressure levels.5
Multiple measurements were taken with
Nexﬁn and IBP at each of the six time-
points because they are continuous measur-
ing devices and the mean of the values was
subsequently calculated.
Statistical analyses
This study was approved by the institutional
review board as a pilot study because of its
intention to provide background informa-
tion for the preparation of a larger investi-
gation. In this respect, no formal power
analysis was performed and the design and
patient group were chosen to inform the
study design and protocol of the larger
study.21 The study was performed in mod-
erate risk orthopaedic surgery patients
undergoing knee and hip replacement
because the Nexﬁn device could be used to
provide continuous BPmeasurement without
the risk of invasive arterial cannulation-
related side-eﬀects.16Measurements recorded
from the IBP device were used as the ‘gold
standard’ reference measurements. For data
collection and analyses, Microsoft Excel 2010
for Windows (Microsoft, Redmond, WA,
USA),MedCalc (MedCalc Software, Ostend,
Belgium) and R version 3.0.1 (R Foundation
for Statistical Computing, Vienna, Austria)
were used.
Pearson correlation coeﬃcients and Bland–
Altman plots were used to evaluate the correl-
ation between the measurements acquired by
the three devices. The Bland–Altman method
uses the plot of the diﬀerence in BP for each
patient (i.e. IBP – Nexﬁn or IBP – NIBP)
against themean of the twomeasurements.22,23
The Bland–Altman method calculates the
mean diﬀerence between two methods of
measurement (‘bias’) and 95% limits of agree-
ment (LOA) as the mean diﬀerence (2 SD).
The smaller the range is between these two
limits, the better is the agreement. A mean
percentage error (PE) <30% also indicated
suﬃcient agreement between the devices.22,23
In addition, polar plots were used to compare
trending ability between the three methods
with the accepted range of ‘angle/angular bias
30’ reﬂecting the 95% conﬁdence inter-
val.24,25 Regression analyses were also per-
formed to adjust for confounders in
morphometric data. All tests were part of an
exploratory data analysis and so no adjust-
ments for multiple testing were made. In all
analyses, a P-value <0.05 was taken to indi-
cate statistical signiﬁcance.
Results
Data were available from 20 patients who
underwent moderate risk reconstructive
orthopaedic surgery. The baseline demo-
graphic and surgery-related data of the
study participants are shown in Table 1.
The Nexﬁn ﬁnger cuﬀ could be easily
placed on all patients and no adverse out-
comes were observed.
Nexfin versus IBP measurements
A comparison of the pooled data from
all systolic BP, diastolic BP and MAP
Table 1. Demographic baseline characteristics for
patients undergoing hip or knee surgery and moni-





Age, years 68 10
Height, cm 171 7
Weight, kg 78 21




Data presented as mean SD or n of patients.
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measurements made with the IBP device
and with the Nexﬁn device are shown in
Table 2. Figure 1 shows the Pearson correl-
ation plots (A to C) and the Bland–Altman
plots (D to F) for the comparison between
the mean Nexﬁn and IBP measurements
for systolic BP, diastolic BP and MAP.
Measurements from the Nexﬁn device
correlated well with the IBP measurements
as indicated by the Pearson correlation
coeﬃcients (Table 2). For MAP, there was
a suﬃcient correlation between IBP/Nexﬁn
(Pearson¼ 0.75). Nexﬁn underestimated
systolic BP as indicated by positive mean
Figure 1. Pearson correlation plots between Nexfin (NexF) and invasively measured blood pressure (IBP)
for mean (a) systolic (syst), (b) diastolic (diast), and (c) mean arterial blood pressure (map) values. Bland–
Altman plots between Nexfin and IBP for mean (d) systolic (syst), (e) diastolic (diast), and (f) mean arterial
blood pressure (map) measurements.
Table 2. Comparison of blood pressure (BP) measurements (Riva-Rocci technique8) taken by
the Nexfin device and invasive BP (IBP) device (n¼ 20).











Systolic BP 5 16 26.5, 36.9 25 0.81
Diastolic BP 5 12 29.6, 19.5 33 0.65
Mean arterial pressure 1 13 25.5, 24.0 27 0.75
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diﬀerence (bias) whereas diastolic BP and
MAP were slightly overestimated as shown
by negative mean diﬀerences (Table 2). The
PE of the systolic BPNexﬁn
 and MAPNexﬁn

were within the clinically accepted range
(i.e. <30%). However, the PE for diastolic
BPNexﬁn
 (33%) was greater than the
accepted range.
Regression analysis showed that age had an
impact on BMI, height and weight (P< 0.05)
and so these parameters were adjusted accord-
ingly. Further analyses showed that BMI and
weight/height had no impact on the mean
diﬀerence (bias) of MAPNexﬁn
 with respect to
MAPIBP (BMI univariate, P¼ 0.48; BMI
adjusted for age, P¼ 0.51; weight and height
adjusted for age, P¼ 0.29 and P¼ 0.27,
respectively).
NIBP versus IBP measurements
A comparison of the pooled data from all
systolic BP, diastolic BP and MAP meas-
urements made by the IBP device and the
NIBP device are shown in Table 3. Figure 2
shows the Pearson correlation plots (A to C)
and the Bland–Altman plots (D to F) for
the comparison between NIBP and IBP
measurements for systolic BP, diastolic BP
and MAP.
Measurements by the NIBP method cor-
related well with the IBP measurements as
indicated by the Pearson correlation coeﬃ-
cients (Table 3). The Pearson correlation
coeﬃcient between IBP/NIBP was 0.70. The
NIBPmeasurements markedly underestimated
systolic BP, diastolic BP and MAP as shown
by positive mean diﬀerences (bias) (Table 3).
Only the PE of systolic BP was within the
clinically accepted range (i.e. <30%).
Regression analysis showed that BMI
and weight/height had no impact on the
mean diﬀerence (bias) of MAPNIBP with
respect toMAPIBP (BMI univariate, P¼ 0.7;
BMI adjusted for age, P¼ 0.41; weight
and height adjusted for age, P¼ 0.48 and
P¼ 0.71).
MAP measured by the three different
methods at different time-points
Values for the diﬀerences in MAP assessed
by the three diﬀerent methods at diﬀerent
time-points are presented in Table 4.
As shown by PE, Nexﬁn always correlated
well with IBP (i.e. <30%) except at T3.
These ﬁndings were conﬁrmed by Pearson
correlation coeﬃcients. Measurements by
NIBP correlated with IBP measurements at
T0 and T15 but at none of the other time-
points (Table 4).
The trending ability of IBP with Nexﬁn
and IBP with NIBP are presented in polar
plots in Figure 3. The trending ability of
Nexﬁn was comparable with NIBP using
IBP as a reference (i.e. measurements were
within the accepted range of angle/angular
bias 30).
Table 3. Comparison of blood pressure (BP) measurements (Riva-Rocci technique8) taken by
traditional oscillometric, non-invasive pressure (NIBP) and invasive BP (IBP) devices (n¼ 20).











Systolic BP 10 14 18.1, 37.1 22 0.85
Diastolic BP 5 11 17.6, 27.6 33 0.63
Mean arterial pressure 13 13 12.7, 38.4 30 0.70
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Figure 2. Pearson correlation plots between non-invasively measured blood pressure (NIBP) and mean
values for invasively measured BP (IBP) for (a) systolic (syst), (b) diastolic (diast), and (c) mean arterial blood
pressure (map) values. Bland–Altman plots between NIBP and mean values for IBP for (d) systolic (syst),
(e) diastolic (diast), and (f) mean arterial blood pressure (map) measurements.
Table 4. Comparison of mean arterial blood pressure (MAP) measurements taken by the three methods
(i.e. Nexfin/invasive blood pressure [IBP]/non-invasive pressure [NIBP]) at different time-points.
Time Comparison











T0 IBP – Nexfin
 1 14 27, 26 26 0.71
IBP – NIBP 13 12 11, 37 24 0.76
T3 IBP – Nexfin
 1 15 28, 30 34 0.30
IBP – NIBP 15 14 12, 42 35 0.52
T15 IBP – Nexfin
 0 13 26, 26 27 0.67
IBP – NIBP 13 12 11, 37 28 0.69
T20 IBP – Nexfin
 1 9 19, 17 19 0.84
IBP – NIBP 12 13 13, 37 30 0.57
T30 IBP – Nexfin
 0 9 18, 18 21 0.86
IBP – NIBP 11 13 14, 36 31 0.60
TEnd IBP – Nexfin
 5 11 27, 17 27 0.83
IBP – NIBP 8 12 16, 32 33 0.79
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Discussion
The usefulness of haemodynamic monitoring
in surgery has long been acknowledged.14–16
For example, prolonged intraoperative
decreases of 20mmHg or more in MAP
were associated with a signiﬁcant increase
in risk for postoperative ischaemic compli-
cations in patients undergoing elective
non-cardiac surgery.26 In another study,
there were more complications among
hypertensive and diabetic patients whose
MAP decreased to less than 70mmHg.27
Moreover, intraoperative arterial hypoten-
sion is associated with prolonged length of
hospital stay and increased mortality.14,28,29
In addition, an intraoperative systolic BP
variability outside a targeted BP range (e.g.
BP> 135mmHg or< 90mmHg) has been
shown to predict 30-day postoperative mor-
tality.30 Nevertheless, the placement of an
indwelling arterial catheter is not without
risk.2 The results of this present study show
that the non-invasive Nexﬁn monitor pro-
vides the clinician with continuous recon-
structed arterial BP waveforms, which, from
a clinical standpoint, could be used in mod-
erate risk patients as an alternative to IBP.
This current prospective, observational
pilot study involving 20moderate risk patients
scheduled for elective orthopaedic surgery,
showed that continuous non-invasive BP
measurements with Nexﬁn were comparable
with continuous IBP measurements and
tended to be more precise than the traditional
intermittent NIBPmeasurements. The current
results showed that for MAP, there was
suﬃcient correlation between Nexﬁn and
IBP measurements, which was better than the
correlation between NIBP and IBP measure-
ments. Nexﬁn only underestimated the sys-
tolic BP whereas NIBP underestimated all
Figure 3. Polar plots displaying the trending ability of (a) mean IBP and Nexfin values and (b) mean IBP
values and NIBP for mean arterial pressure (MAP) measurements. Radial ULOA, radial upper limit of
agreement; Radial LLOA, radial lower limit of agreement.
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arterial BP readings. In addition, the trending
ability for MAPNexﬁn
 was comparable with
MAPIBP indicating that deviations from
the gold standard (IBP) were consistently in
the same direction. The current results are
in agreement with previous studies,31,32
and suggest that Nexﬁn is a reliable measure
of procedure-related, minor-to-moderate
haemodynamic variations in moderate risk
patients.33 Only at one time-point did the PE
of MAPNexﬁn
 fall outside the clinically
accepted range of <30%. This observation
supports the possible interchangeability of
IBP with Nexﬁn for recording MAP.
Consistent with these current results, accur-
ate non-invasive BP measurements using
another ﬁnger-clamp system (CNAP) have
been reported during vascular surgery.34
Previous studies have also suggested that
the continuous Nexﬁn monitor might
improve the detection of BP changes com-
pared with NIBP measurements.35,36
In a recent study, involving haemo-
dynamically stable patients undergoing gen-
eral anaesthesia for elective surgery, the
agreement of Nexﬁn-derived MAP with
invasive MAP measurements was found to
be non-inferior to conventional MAP meas-
urements obtained with intermittent arm
cuﬀ oscillometry.16 In patients scheduled
for elective coronary surgery, MAPNexﬁn

also correlated with both radial and femoral
derived IBP before and after cardiopulmon-
ary bypass and reﬂected percentage changes
in MAP.31 In addition, Nexﬁn monitoring
reduced the length of intraoperative arterial
hypo- and hypertension compared with
NIBP monitoring.37 Moreover, in 45 critic-
ally ill patients, an excellent correlation
between MAPNexﬁn
 and femoral MAPIBP
was preserved in a subgroup analysis of
patients with severe hypotension, high sys-
temic vascular resistance, low cardiac
output, hypothermia and in patients sup-
ported by inotropic and/or vasopressive
agents.32 Nevertheless, in a previous study
in critically ill and postoperative cardiac
surgery patients, Nexﬁn-derived measure-
ments did not correlate with traditional
invasive measurements.11 This may partially
be explained by a worse peripheral perfusion
status in the second study and/or diﬀerences
in patient-related factors, (e.g. obesity) in
these patients.11 However, in this present
study, patient related-factors (e.g. BMI,
weight and height), did not inﬂuence the
accuracy of Nexﬁn measurements.
The correlation coeﬃcients between IBP
and Nexﬁn devices observed during this
study (i.e. 0.65 to 0.81) were not as high as
those previously described in cardiac surgery
patients (i.e. 0.96).9 The diﬀerence in these
ﬁndings might be explained by the diﬀerence
in the type of surgery (i.e. cardiac versus
orthopaedic). In contrast to a more static
patient positioning in cardiac surgery, at our
centre, patient positioning in orthopaedic
surgery is more dynamic due to the fact that
one arm is continuously raised to gain an
improved operative access to the ipsilateral
side in hip surgery and to the surgical
interventions (i.e. screwing, drilling and
tilling). Nevertheless, in this present study,
a review of mean diﬀerences (bias) and
LOAs indicate that MAPNexﬁn
 appeared
to be as precise as MAPIBP. Furthermore,
the percentage error for MAPNexﬁn
 and
MAPIBP was comparable with previous
ﬁndings in non-cardiac surgery patients.16
Consistent with previous results, com-
pared with Nexﬁn values, NIBP values
were lower than IBP values overall and at
every given time-point.16 Although based on
the same reference technique and cut-oﬀ
values,16 the PE in this present study was
outside the accepted range for NIBP values
on four out of six time-points. Therefore,
NIBP measurements were less precise than
Nexﬁn measurements and underestimated
BP. This discrepancy has also been detected
between NIBP and IBP measurements in
critically ill patients.38,39 NIBP values have
been shown to be especially inaccurate in
overweight critically ill patients, which can
840 Journal of International Medical Research 44(4)
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lead to erroneous interpretations of BP.40
This may partially be explained by improper
NIBP cuﬀ size,41 cuﬀ placement site42 and
inconsistency of Korotkoﬀ sounds.43
Nevertheless, in this present study, the
trending ability of NIBP was comparable
with that of Nexﬁn.
The study had several limitations. For
example, it was a pilot study and so the
results were obtained from a small number
of patients undergoing the same type of
surgery (i.e. elective orthopaedic surgery).
Therefore, it was not possible to determine
the interchangeability of Nexﬁn and IBP
devices under diﬀerent conditions as well
as in emergency situations. More studies are
required in other patient groups to demon-
strate the clinical usefulness of the Nexﬁn
device. In addition, ﬁngertip temperature
measurements on the Nexﬁn hand to
monitor disturbances in microperfusion
(e.g. cold-mediated vasoconstriction) were
not performed, which might have aﬀected
the accuracy of the measurements. Moreover,
inter-observer variability between the four
assessors was not assessed, which may have
also had an impact on the overall results.
In conclusion, BP monitoring with the
Nexﬁn device was feasible in this small
group of patients undergoing orthopaedic
surgery with general anaesthesia. It provided
the clinician with a continuous, beat-to-beat,
real-time BP monitoring that appeared to be
comparable with IBP monitoring in these
moderate risk patients. Furthermore, Nexﬁn
measurements tended to be more precise than
NIBP measurements and had the advantage
of being measured continuously. The absence
of arterial cannulation-related side-eﬀects
renders non-invasive continuous BP monitor-
ing a promising approach in the context of
both patient safety and comfort. The results
of this present study suggest that a high
number of patients with a moderate peri-
operative risk could be optimized using the
Nexﬁn device. Given the comparability in
accuracy and trending ability of non-invasive
continuous BP monitoring versus the current
gold standard of IBP, further studies should
target the implications on patient outcome
related to the application of this new tech-
nology. Furthermore, future investigations
should focus on the interchangeability of
Nexﬁn and IBP devices under diﬀerent
situations.
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